Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
about
Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapiesOverlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functionsTherapeutic cancer vaccines and combination immunotherapies involving vaccinationElimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.DNA is an efficient booster of dendritic cell-based vaccineAntigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes.Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells.Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine.Tolerogenic dendritic cells and their potential applications.Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.NK cells: key to success of DC-based cancer vaccines?Dendritic cells: cellular mediators for immunological toleranceOncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostDC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010.Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs.Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity.
P2860
Q26830839-34625C2D-8ACA-459A-BF9B-CB74B546C1CDQ27014714-8194F1BD-BC6A-47B7-84E0-7474BC639EFDQ28397609-F81DC4DE-4D54-4B33-8334-ABB01F5A948FQ33679779-ED4A4189-0E87-4A08-8850-F91FE41BF4F8Q34585798-0AC6D09C-67C9-45F6-BFDB-3471E1FB3AD9Q34658452-679AA88B-9677-4301-AB96-801666555D84Q35802152-0B381F27-3BBC-4E34-8CA5-05319AAAEEE4Q36256389-A5BF3AE7-3E71-41D5-A12A-02AFAF34E5F6Q36718256-BC2929D9-87AB-4401-B60D-D0FE3268F980Q37346827-7FF3BB08-9853-40B7-B1C9-075883404FA9Q37686631-C05EDDA2-E0C3-4AA0-B109-38F4766F23D5Q37826217-5BE120A3-5426-4472-BF21-3E7B6C0F73C4Q38002844-B1E51986-BBDD-4166-B137-AD642705B11BQ38036202-952859D6-F3EE-473B-A592-C9F2DC4FE97FQ38114071-3ED981E7-D71B-4BA2-8691-7E06739FE8A4Q38369289-79035394-9955-430A-B8F5-F23DF70C3B69Q40007199-7C79BEBD-5734-4871-AB4C-31DB3B3555B5Q41853661-0CBB9B91-AF66-466C-B597-B7A1387F97D5Q41963722-59C5EC0F-9094-4195-9407-CB0EE9C126BAQ41993616-2F3CC8DB-863B-4BE4-96D7-279A463E7E57Q52647360-53AB3015-82A6-4F65-B597-FF7011F76786
P2860
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
@en
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.
@nl
type
label
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
@en
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.
@nl
prefLabel
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
@en
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.
@nl
P2860
P1476
Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4
@en
P2093
Pawel Kalinski
P2860
P304
P577
2009-06-01T00:00:00Z